Constellation Pharmaceuticals Inc

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Report date

6/30/2021

Quarter

2021 Q2

Filed

8/16/2021

Shares

37,958

Value ($000)

1,283

Weight

0.0%

2020 Q2 - 2021 Q2 (5 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2021 Q2	8/16/2021	1,283	0.0%	37,958	6/30/2021
2021 Q1	5/14/2021	734	0.0%	31,369	3/31/2021
2020 Q4	3/1/2021	751	0.0%	26,069	12/31/2020
2020 Q3	11/13/2020	607	0.0%	29,969	9/30/2020
2020 Q2	8/14/2020	627	0.0%	20,852	6/30/2020